When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KYKOF - Ultragenyx files U.S. application for expanded use of Crysvita
Kyowa Hakko Kogyo
Ultragenyx (NASDAQ:RARE) and collaboration partner Kyowa Kirin (OTCPK:KYKOF) announce the filing of a supplemental marketing application in the U.S. seeking approval to use Crysvita (burosumab) to treat FGF23-related hypophosphatemia associated with phosphaturic mesenchymal tumors (tumor-induced osteomalacia) that cannot be curatively resected or localized.
More news on: Ultragenyx Pharmaceutical Inc., Kyowa Kirin Co., Ltd., Healthcare stocks news,